Your search returned 1627 results.

Results
	1.	One size doesn't fit all. [electronic resource] by Lechner-Scott, Jeannette Giovannoni, Gavin Hawkes, Chris Levy, Michael Waubant, Emmanuelle Producer: 20190807 In: Multiple sclerosis and related disorders vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Natalizumab wearing-off effect: The hunt for the elusive pharmacodynamic biomarker. [electronic resource] by Foley, John F Stuve, Olaf Producer: 20201009 In: Neurology(R) neuroimmunology & neuroinflammation vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab. [electronic resource] by Harrer, A Lang, R Kölblinger, P Producer: 20201204 In: The British journal of dermatology vol. 183 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Clinical commentary on 'Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis', by Foley et al. [electronic resource] by Chan, Andrew Producer: 20190813 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Maternal and fetal risks of natalizumab exposure in utero: A fine balance. [electronic resource] by Marrie, Ruth Ann Producer: 20190723 In: Neurology vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not "mind the gap". [electronic resource] by Mowry, Ellen M Bourdette, Dennis Producer: 20200128 In: Neurology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Can natalizumab be beneficial in acute ischaemic stroke? [electronic resource] by Tatlisumak, Turgut Producer: 20180917 In: The Lancet. Neurology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Dosing interval of natalizumab in MS: Do good things come to those who wait? [electronic resource] by Clifford, David B Tyler, Kenneth L Producer: 20200121 In: Neurology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing". [electronic resource] by van Kempen, Zoé LE Rispens, Theo Killestein, Joep Producer: 20190508 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Late activity rebound in non-active multiple sclerosis: A rare event. [electronic resource] by Corti, Lucas Ayrignac, Xavier Carra Dalliere, Clarisse Charif, Mahmoud de Sèze, Jérome Biotti, Damien Ciron, Jonathan Labauge, Pierre Producer: 20190528 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	[Natalizumab treatment in multiple sclerosis]. [electronic resource] by Tanaka, Masami Producer: 20160811 In: Rinsho shinkeigaku = Clinical neurology vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	New fungal infections associated with disease-modifying treatments in MS. [electronic resource] by Correale, Jorge Producer: 20200220 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay. [electronic resource] by Ontaneda, Daniel Fox, Robert J Gagne Brosseau, Marie-Sarah Stobbe, Gary Wundes, Annette Producer: 20190604 In: Neurology vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Letter to the editor on the paper: "The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing". [electronic resource] by Sehr, Tony Proschmann, Undine Thomas, Katja Ziemssen, Tjalf Producer: 20190508 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Reader response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. [electronic resource] by Sotgiu, Stefano Eusebi, Anna Begliuomini, Chiara Guerini, Franca R Carta, Alessandra Producer: 20190819 In: Neurology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Reader response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. [electronic resource] by Proschmann, Undine Akgün, Katja Ziemssen, Tjalf Producer: 20190819 In: Neurology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. [electronic resource] by Portaccio, Emilio Amato, Maria Pia Producer: 20190819 In: Neurology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	A review of the evidence for a natalizumab exit strategy for patients with multiple sclerosis. [electronic resource] by Sellner, Johann Rommer, Paulus Stefan Producer: 20190408 In: Autoimmunity reviews vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Reply. [electronic resource] by Fissolo, Nicolas Pignolet, Béatrice Brassat, David Comabella, Manuel Producer: 20190523 In: Annals of neurology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Letter to the editor regarding "Therapeutic drug monitoring of natalizumab". [electronic resource] by Proschmann, Undine Sehr, Tony Akgün, Katja Ziemssen, Tjalf Producer: 20200820 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1627 results.